Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • New York guideNew York Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFQRFQ Meaning: What Is an RFQ?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›New York
  4. ›Healthcare and Medical Services
  5. ›Gamifant (Emapalumab-Izsg) 5mg/ml, 10ml

State University of New York (SUNY)·New York

Gamifant (Emapalumab-Izsg) 5mg/ml, 10ml

Closes 12/29/2025$50k – $125kRequest for QuotationLogin required
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

Stony Brook University Hospital Receiving, 101 Nicolls Road, Stony Brook, New York 11794 Stony Brook University Hospital intends to purchase Gamifant (Emapalumab-Izsg) 5mg/ml, 10ml manufactured by Sobi and Distributed by Mckesson Specialty under its discretionary authority, pursuant to NYS Education Law §355(5)(A), which is up to $125,000, for the above noted commodity/product or service. A sealed bid will not be held. If you are interested in providing a proposal for the above commodity/product or service, you must contact the appropriately designated Campus contact in this advertisement within 15 business days of this Advertisement Notice. This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Failure to comply with this requirement can range from no contract to debarment from sales to any NYS Agency. Successful contractor shall be required to complete and submit documents related to Vendor Responsibility, NYS Finance Law 139, NYS Tax Law Section 5-a, and valid/current NYS Workers’ Compensation and Disability Forms. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: Awarded to McKesson Plasma & Biologics, Q23-087.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Robert Meyn(Sr Procurement Officer)

[email protected]

(631) 444-4068

Key dates

Opened
12/5/2025
Closes
12/29/2025

Last updated

Details

Type
Request for Quotation
Industry
Healthcare and Medical Services
NAICS
325412
Solicitation №
SQ25-103

Budget estimate

$50,000 – $125,000

The budget for this opportunity is likely to be around $50,000 to $125,000, as it falls under the discretionary procurement authority of up to $125,000. The exact amount will depend on the proposal submitted by the vendor and the negotiations with the State University of New York (SUNY). Factors that may influence the likely payment range include the cost of the product, the quantity required, and the vendor's pricing strategy.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Veterans Affairs·Illinois

Top match · 62%

6505--Ramipril Capsules RFP

Closes 11/23/2026Opened 10/29/2026

U.S. Department Of Veterans Affairs·California

62% match

6550--Blood Type IVD Reagents

Closes 11/16/2026Opened 10/30/2026

U.S. Food and Drug Administration·United States of America

62% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

61% match

Minor Use Minor Species Development of Drugs (R01)

Rolling / TBD closeOpened 11/30/2023

U.S. Department Of Veterans Affairs·Washington

61% match

6550--Cepheid GeneXpert Testing Supplies

Closes 11/16/2026Opened 9/22/2026

U.S. Department Of Veterans Affairs·Texas

61% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. Department Of Health And Human Services·United States of America

60% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. Department Of Veterans Affairs·Maryland

60% match

6550--Cepheid GeneXpert Testing Supplies

Closes 11/16/2026Opened 9/22/2026

U.S. Department Of Defense·New Jersey

60% match

AZITHROMYCIN TABLETS

Closes 3/23/2028Opened 6/29/2021

Colorado Parks and Wildlife·Colorado

60% match

Apishapa SWA Cheatgrass Treatment

Closes 11/6/2026Opened 10/30/2026

U.S. Department Of Defense·New York

60% match

Quetiapine Fumarate XR Tablets

Closes 10/17/2029Opened 3/6/2023

U.S. Department Of Defense·Maryland

60% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 10/18/2024

U.S. Department Of Defense·Maryland

60% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 9/23/2026

U.S. National Institutes of Health·United States of America

60% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

60% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. Food and Drug Administration·United States of America

60% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Energy·Ohio

60% match

TECHNOLOGY LICENSING OPPORTUNITY: NanoFET

Closes 12/17/2026Opened 6/17/2026

U.S. Department Of Health And Human Services·Arizona

60% match

WRSU - Simplifi Med Trays

Closes 11/9/2026Opened 10/29/2026

U.S. Department Of Veterans Affairs·United States of America

60% match

6505--FY27 Lenalidomide BPA

Closes 11/12/2026Opened 10/30/2026

U.S. Department Of Energy·New Mexico

59% match

TIDAL: Target-Induced Droplet Assembly of Ligands

Closes 12/8/2026Opened 9/8/2026

U.S. Department Of Defense·Florida

59% match

Ibuprofen 400MG/600MG/800MG Tablets

Closes 2/12/2029Opened 2/15/2023

U.S. National Institutes of Health·United States of America

59% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

Illinois Emergency Mgt Agency·Illinois

59% match

Emergency Management Performance Grants

Rolling / TBD closeOpened 6/1/2021

U.S. Food and Drug Administration·United States of America

59% match

Minor Use Minor Species Development of Drugs (R01)

Closes 1/29/2027Opened 5/29/2024

U.S. National Institutes of Health·United States of America

59% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024